CUSHING SYNDROME

Clinical trials for CUSHING SYNDROME explained in plain language.

Never miss a new study

Get alerted when new CUSHING SYNDROME trials appear

Sign up with your email to follow new studies for CUSHING SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 7 Not yet recruiting 1 Not yet finished but already full! 1

New hope for cushing syndrome: Long-Term drug safety trial underway

Disease control Ongoing

This study looks at the long-term safety of a drug called relacorilant for people with Cushing syndrome. It includes 125 adults who already completed a prior study and may benefit from continuing treatment. The main goal is to track any side effects over time.

Matched conditions: CUSHING SYNDROME

Phase: PHASE2 • Sponsor: Corcept Therapeutics • Aim: Disease control

Last updated May 17, 2026 03:58 UTC

CUSHING SYNDROME

Get alerted when new CUSHING SYNDROME trials appear

New hope for cushing syndrome: Long-Term drug safety trial underway